Drug: auranofin

The most common side effect of auranofin is loose stools or diarrhea. Stomach pain, nausea, weight loss, and skin inflammation can occur. An itching sensation can be an early warning sign of a skin reaction, such as a rash. Auranofin also can cause a metallic taste and mouth sores, though less frequently than injectable gold salts. Because gold salts can cause serious kidney and bone marrow problems, all patients require monitoring with regular testing of blood and urine. Hair loss, anemia, and reduced number of white blood cells or platelets have also been reported. Reference: FDA Prescribing Information
Last Editorial Review: 9/10/2012

Source: http://www.medicinenet.com

Yes

Source: http://www.medicinenet.com

Capsule: 3 mg.

Source: http://www.medicinenet.com

Auranofin should be stored between 15 C and 30 C (59 F and 86 F) and dispensed in a tight, light-resistant container

Source: http://www.medicinenet.com

The usual adult dosage of auranofin is 3 mg twice daily or 6 mg once a day. The dose may be increased to 3 mg three times daily after three months.

Source: http://www.medicinenet.com

There are no adequate studies in pregnant women. Use of auranofin in pregnant women is not recommended.

Source: http://www.medicinenet.com

Auranofin has been found in the breast milk of nursing mothers. Nursing during auranofin therapy is not recommended.

Source: http://www.medicinenet.com

Health Services in Toronto

Drug Database Online

Welcome to WebHealthNetwork an online drug guide and dictionary, here you can get drug information and definitaions for most popular pharmaceutical and medicinal drugs, and specifically auranofin. Find what medications you are taking today.